DARE logoDARE
Dare Bioscience Inc

25,189
Loading...
Loading...
News
all
press releases
Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Lags Revenue Estimates
Dare Bioscience (DARE) delivered earnings and revenue surprises of +18.18% and -103.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
More News
News Placeholder
Immatics (IMTX) Reports Q2 Loss, Misses Revenue Estimates
Immatics (IMTX) delivered earnings and revenue surprises of -73.68% and -62.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Editas Medicine (EDIT) Reports Q2 Loss, Tops Revenue Estimates
Editas (EDIT) delivered earnings and revenue surprises of -53.66% and +320.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Misses Revenue Estimates
C4 Therapeutics (CCCC) delivered earnings and revenue surprises of +2.63% and -0.57%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Arvinas, Inc. (ARVN) Reports Q2 Loss, Misses Revenue Estimates
Arvinas (ARVN) delivered earnings and revenue surprises of +3.45% and -53.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?
Zacks·4mo ago
News Placeholder
Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates
Zacks·5mo ago
News Placeholder
Acadia Healthcare (ACHC) Beats Q1 Earnings Estimates
Zacks·5mo ago
News Placeholder
Earnings Preview: Retail Investors Display Uncertainty And Bearishness For Barrick Gold And Rumble
Barrick Gold is expected to report earnings per share (EPS) of $0.28 and a revenue of $3.13 billion. Meanwhile, Rumble is expected to post an earnings loss of $0.15 and a revenue of $19.69 million.
Stocktwits·1y ago
News Placeholder
Dare Bioscience files to sell 15M shares of common stock for holders
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago

Latest DARE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.